Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 220 | 235 | 250 | 251 | 1,309 |
| Gross Profit | 220 | 235 | 250 | 251 | 1,309 |
| Operating Expenses | 17,160 | 12,927 | 22,408 | 26,298 | 20,795 |
| Operating Income | -16,940 | -12,692 | -22,158 | -26,047 | -19,486 |
| Other Income | -4,445 | -4,079 | 761 | -1,052 | -113 |
| Pre-tax Income | -21,385 | -16,771 | -21,397 | -27,099 | -19,599 |
| Net Income Continuous | -21,385 | -16,771 | -21,397 | -27,099 | -19,599 |
| Net Income | $-21,385 | $-16,771 | $-21,397 | $-27,099 | $-19,599 |
| EPS Basic Total Ops | -0.10 | -0.12 | -0.15 | 0.01 | -0.20 |
| EPS Basic Continuous Ops | -0.10 | -0.12 | -0.15 | 0.00 | -0.20 |
| EPS Diluted Total Ops | -0.10 | -0.12 | -0.15 | 0.01 | -0.20 |
| EPS Diluted Continuous Ops | -0.10 | -0.12 | -0.15 | 0.00 | -0.20 |
| EBITDA(a) | $-16,228 | $-12,101 | $-21,543 | $-25,376 | $-18,854 |